@ Newsroom | SEBIO

Transition Therapeutics Shareholders Approve Acquisition by OPKO Health

Posted by on Aug 29, 2016 in Newsroom | 0 comments

MIAMI, FL. – OPKO Health, Inc. (Nasdaq: OPK), announces that at a Special Shareholder Meeting held on August 25, 2016 shareholders of Transition Therapeutics, Inc. (NASDAQ:TTHI, TSX: TTH) holding approximately 93% of the outstanding common shares, voted to approve the previously announced agreement under which OPKO Health will acquire Transition Therapeutics. The acquisition is subject to final approval of the Ontario Superior Court Justice (the “Court”). The Court hearing for the final order is scheduled to take place on August 29, 2016, and the acquisition is expected to close on...

Read More

Novan Files for IPO to Finance ‘Nitric Oxide on Demand’ Skin Drugs

Posted by on Aug 29, 2016 in Newsroom | 0 comments

DURHAM, N.C. – Novan, a company researching ways to harness nitric oxide for drugmaking, has filed for an initial public offering to fund clinical work on treatments for an array of skin conditions. Durham, NC-based Novan set a preliminary target of $60 million for the IPO, a figure that may change as the company works through how many shares it will sell and at what price. In its prospectus filed with securities regulators on Wednesday, Novan says proceeds from the stock offering would fund its lead drug, a topical gel for acne known as SB204, all the way through an application for...

Read More

Mayne Pharma Acquires Rights to a Portfolio of Dermatology Foam Products Including Fabior® and Sorilux®

Posted by on Aug 19, 2016 in Newsroom | 0 comments

GREENVILLE, N.C. – Mayne Pharma (ASX: MYX) is pleased to announce it has acquired a portfolio of on-market dermatology Foam Assets from GSK for US$50.1 million. The Foam Assets include US rights to Fabior and Sorilux, Canadian rights to Luxiq® and Olux-E® and Mexican rights to betamethasone foam. Under the terms of the agreement Mayne Pharma will acquire the approved regulatory filings, trademarks, marketing materials, select product inventory, related medical and technical data and will acquire or obtain licenses for related patents. Fabior (tazarotene) Foam, 0.1% is a...

Read More

Merz Acquires Aesthetics Medical Device Company ON Light Science

Posted by on Aug 16, 2016 in Newsroom | 0 comments

RALEIGH, N.C. – Merz North America announced today it has expanded its aesthetic portfolio through the acquisition of ON Light Sciences, Inc. – a U.S. medical device company developing technologies to enhance laser-based dermatologic procedures, including the FDA 510(k) cleared and CE marked DeScribe® Transparent PFD (perfluorodecalin)patch used in laser tattoo removal. “The addition of ON Light Sciences’ innovative technology allows us to better meet the needs of aesthetic practices that focus on energy-based devices,” said Philip Burchard, CEO of Merz Pharma Group. “We...

Read More

S.C. Dept. of Commerce partners with SCBIO to attract more life sciences

Posted by on Aug 12, 2016 in Newsroom | 0 comments

COLUMBIA, S.C. – A new partnership between the state and a life sciences trade organization could usher in a new era in biotechnology growth in the Upstate and South Carolina. The South Carolina Biotechnology Industry Organization (SCBIO) will work with the South Carolina Department of Commerce on a strategic plan that includes attracting more life sciences sectors to the state, says Wayne Roper, president of SCBIO, which was formed in 2004 and became a self-sustaining membership-driven trade association six years ago. “We have the expertise and the interest in developing the job,”...

Read More

French Firm Buys Morrisville’s kSep for $28M

Posted by on Aug 12, 2016 in Newsroom | 0 comments

MORRISVILLE, N.C. – kSep Systems, a small Morrisville medical device company, has been purchased by French biopharmaceutical equipment supplier Sartorius Stedim Biotech (SSB) for $28 million. The privately owned kSep was formed in 2011 as a spinoff of Durham-based KBI Biopharma, which was itself acquired in 2015 by JSR Group, CMIC Holdings and Inovation Network Corporation of Japan. SSB said it would keep the company’s five employees and continue operations from the Morrisville site. kSep has developed and markets single-use, fully automated centrifugation systems used for...

Read More